Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile

被引:21
|
作者
Odenholt, Inga [1 ]
Walder, Mats
Wullt, Marlene
机构
[1] Lund Univ, Dept Clin Sci, Infect Dis Res Unit, SE-20502 Malmo, Sweden
[2] Lund Univ, Dept Expt Sci, Malmo, Sweden
关键词
pharmacodynamic effect; postantibiotic effect; postantibiotic sub-MIC effect; Clostridium difficile; vancomycin; metronidazole; fusidic acid; STAPHYLOCOCCUS-AUREUS; DIARRHEA; SUSCEPTIBILITY; INFECTION; COLITIS; INVIVO; CIPROFLOXACIN; ROXITHROMYCIN; OUTBREAK; INVITRO;
D O I
10.1159/000104471
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Pharmacodynamic studies of antibiotics have attracted great interest in recent years. However, studies on the pharmacodynamics of different antibiotics against Clostridium difficile are scarce. Methods: The postantibiotic effects (PAE) and the postantibiotic sub-minimum inhibitory concentration (MIC) effects (PA SME) of vancomycin, metronidazole and fusidic acid were investigated by viable counts against three different strains of C. difficile. The killing rate and extent of the three antibiotics against the same strains were also studied by adding 2, 4, 8, 16 and 32 ! MIC of the three antibiotics, respectively. Results: Metronidazole exerted a very rapid bactericidal effect at concentrations of 8 ! MIC and above against all three strains investigated. Vancomycin gave overall less kill in comparison to metronidazole and was bacteriostatic against two of the three strains. Fusidic acid exerted a concentration-dependent killing against two of the strains. Vancomycin exerted short PAEs and PA SMEs against all three strains. Significantly longer PAEs and PA SMEs were noted for fusidic acid. Metronidazole gave similar short PAEs like vancomycin but longer PA SMEs were noted against two of the investigated strains. Conclusion: Metronidazole exerted the most prominent bactericidal effect greater than fusidic acid and greater than vancomycin. Fusidic acid gave overall the longest PAEs and PA SMEs greater than metronidazole and greater than vancomycin. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 50 条
  • [31] A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies
    Parmar, Sapna R.
    Bhatt, Valkal
    Yang, Jie
    Zhang, Qiao
    Schuster, Michael
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (03) : 172 - 182
  • [32] Metronidazole and vancomycin outcomes for Clostridium difficile-associated diarrhoea in a US hospital database
    Lahue, B. J.
    Davidson, D. M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S69 - S69
  • [33] Fucidic acid use in metronidazole nonresponders with Clostridium difficile infection
    Bektas, Mehmet
    Toeruener, Murat
    Cetinkaya, Hulya
    Soykan, Irfan
    Oezden, Ali
    DIGESTION, 2007, 75 (04) : 177 - 178
  • [34] A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile -: Associated diarrhea, stratified by disease severity
    Zar, Fred A.
    Bakkanagari, Srinivasa R.
    Moorthi, K. M. L. S. T.
    Davis, Melinda B.
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (03) : 302 - 307
  • [35] Comparison of clinical and microbiological response to treatment of Clostridium difficile associated disease with metronidazole and vancomycin
    Al-Nassir, Wafa N.
    Sethi, Ajay K.
    Nerandzic, Michelle M.
    Bobulsky, Greg S.
    Jump, Robin L. P.
    Donskey, Curtis J.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (01) : 56 - 62
  • [36] A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea
    Wullt, M
    Odenholt, I
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) : 211 - 216
  • [37] Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole
    Freeman, Jane
    Baines, Simon D.
    Todhunter, Sharie L.
    Huscroft, Grace S.
    Wilcox, Mark H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (06) : 1407 - +
  • [38] Metronidazole-triazole conjugates: Activity against Clostridium difficile and parasites
    Jarrad, Angie M.
    Karoli, Tomislav
    Debnath, Anjan
    Tay, Chin Yen
    Huang, Johnny X.
    Kaeslin, Geraldine
    Elliott, Alysha G.
    Miyamoto, Yukiko
    Ramu, Soumya
    Kavanagh, Angela M.
    Zuegg, Johannes
    Eckmann, Lars
    Blaskovich, Mark A. T.
    Cooper, Matthew A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 101 : 96 - 102
  • [39] Comparison of the in vitro antibacterial activity of Ramizol, fidaxomicin, vancomycin, and metronidazole against 100 clinical isolates of Clostridium difficile by broth microdilution
    Wolfe, Cindy
    Pagano, Paul
    Pillar, Chris M.
    Shinabarger, Dean L.
    Boulos, Ramiz A.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 92 (03) : 250 - 252
  • [40] Metronidazole resistance in Clostridium difficile is heterogeneous
    Pelaez, T.
    Cercenado, E.
    Alcala, L.
    Marin, M.
    Martin-Lopez, A.
    Martinez-Alarcon, J.
    Catalan, P.
    Sanchez-Somolinos, M.
    Bouza, E.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (09) : 3028 - 3032